[{"orgOrder":0,"company":"Affiris","sponsor":"PROSENEX AmbulatoriumbetriebsGMBH | Medical University Innsbruck | Forschungszentrum J\u00fclich","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"AUSTRIA","productType":"Undisclosed","year":"2014","type":"Inapplicable","leadProduct":"Affitope PD03A","moa":"Alpha-synuclein","graph1":"Neurology","graph2":"Phase I","graph3":"Affiris","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Affiris \/ PROSENEX AmbulatoriumbetriebsGMBH | Medical University Innsbruck | Forschungszentrum J\u00fclich","highestDevelopmentStatusID":"6","companyTruncated":"Affiris \/ PROSENEX AmbulatoriumbetriebsGMBH | Medical University Innsbruck | Forschungszentrum J\u00fclich"},{"orgOrder":0,"company":"Affiris","sponsor":"AC Immune","pharmaFlowCategory":"D","therapeuticArea":"Neurology","country":"AUSTRIA","productType":"Vaccine","year":"2021","type":"Acquisition","leadProduct":"PD01","moa":"Alpha-synuclein","graph1":"Neurology","graph2":"Phase I","graph3":"Affiris","amount2":0.10000000000000001,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Neurology","amount2New":0.10000000000000001,"dosageForm":"Injection","sponsorNew":"Affiris \/ AC Immune","highestDevelopmentStatusID":"6","companyTruncated":"Affiris \/ AC Immune"},{"orgOrder":0,"company":"Affiris","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"AUSTRIA","productType":"Vaccine","year":"2020","type":"Inapplicable","leadProduct":"PD01","moa":"Alpha-synuclein","graph1":"Neurology","graph2":"Phase I","graph3":"Affiris","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Affiris \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"Affiris \/ Undisclosed"},{"orgOrder":0,"company":"Affiris","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"AUSTRIA","productType":"Undisclosed","year":"2010","type":"Inapplicable","leadProduct":"Affitope AD02","moa":"Amyloid-beta","graph1":"Neurology","graph2":"Phase II","graph3":"Affiris","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Affiris \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Affiris \/ Undisclosed"},{"orgOrder":0,"company":"Affiris","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"AUSTRIA","productType":"Undisclosed","year":"2013","type":"Inapplicable","leadProduct":"Affitope AD02","moa":"Amyloid-beta","graph1":"Neurology","graph2":"Phase II","graph3":"Affiris","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Affiris \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Affiris \/ Undisclosed"},{"orgOrder":0,"company":"Affiris","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"AUSTRIA","productType":"Undisclosed","year":"2010","type":"Inapplicable","leadProduct":"Affitope AD02","moa":"Amyloid-beta","graph1":"Neurology","graph2":"Phase II","graph3":"Affiris","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Affiris \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Affiris \/ Undisclosed"},{"orgOrder":0,"company":"Affiris","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"AUSTRIA","productType":"Undisclosed","year":"2011","type":"Inapplicable","leadProduct":"Affitope AD03","moa":"Amyloid-beta","graph1":"Neurology","graph2":"Phase I","graph3":"Affiris","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Affiris \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"Affiris \/ Undisclosed"},{"orgOrder":0,"company":"Affiris","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Genetic Disease","country":"AUSTRIA","productType":"Miscellaneous","year":"2021","type":"Inapplicable","leadProduct":"mAB C6-17","moa":"Mutant huntingtin","graph1":"Genetic Disease","graph2":"Preclinical","graph3":"Affiris","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Genetic Disease","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Affiris \/ Undisclosed","highestDevelopmentStatusID":"4","companyTruncated":"Affiris \/ Undisclosed"},{"orgOrder":0,"company":"Affiris","sponsor":"Medical University of Vienna","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"AUSTRIA","productType":"Undisclosed","year":"2015","type":"Inapplicable","leadProduct":"Affitope AT04A","moa":"PCSK9","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase I","graph3":"Affiris","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Injection","sponsorNew":"Affiris \/ Medical University of Vienna","highestDevelopmentStatusID":"6","companyTruncated":"Affiris \/ Medical University of Vienna"},{"orgOrder":0,"company":"Affiris","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"AUSTRIA","productType":"Vaccine","year":"2021","type":"Inapplicable","leadProduct":"AT04A","moa":"PCSK9","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase I","graph3":"Affiris","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Injection","sponsorNew":"Affiris \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"Affiris \/ Undisclosed"},{"orgOrder":0,"company":"Affiris","sponsor":"Frontier Biotechnologies","pharmaFlowCategory":"D","therapeuticArea":"Cardiology\/Vascular Diseases","country":"AUSTRIA","productType":"Vaccine","year":"2021","type":"Licensing Agreement","leadProduct":"Affitope AT04","moa":"||Undisclosed","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase I","graph3":"Affiris","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Injection","sponsorNew":"Affiris \/ Frontier Biotechnologies","highestDevelopmentStatusID":"6","companyTruncated":"Affiris \/ Frontier Biotechnologies"},{"orgOrder":0,"company":"Affiris","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"AUSTRIA","productType":"Undisclosed","year":"2012","type":"Inapplicable","leadProduct":"Affitope PD01A","moa":"Undisclosed","graph1":"Neurology","graph2":"Phase I","graph3":"Affiris","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Affiris \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"Affiris \/ Undisclosed"},{"orgOrder":0,"company":"Affiris","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"AUSTRIA","productType":"Undisclosed","year":"2014","type":"Inapplicable","leadProduct":"Affitope PD01A","moa":"Undisclosed","graph1":"Neurology","graph2":"Phase I","graph3":"Affiris","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Affiris \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"Affiris \/ Undisclosed"},{"orgOrder":0,"company":"Affiris","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"AUSTRIA","productType":"Undisclosed","year":"2015","type":"Inapplicable","leadProduct":"Affitope PD01A","moa":"Undisclosed","graph1":"Neurology","graph2":"Phase I","graph3":"Affiris","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Affiris \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"Affiris \/ Undisclosed"},{"orgOrder":0,"company":"Affiris","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"AUSTRIA","productType":"Undisclosed","year":"2011","type":"Inapplicable","leadProduct":"ATH03","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase I","graph3":"Affiris","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Affiris \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"Affiris \/ Undisclosed"},{"orgOrder":0,"company":"Affiris","sponsor":"University Hospital, Bordeaux | INSERM | Forschungszentrum J\u00fclich | University Hospital, Toulouse","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"AUSTRIA","productType":"Vaccine","year":"2014","type":"Inapplicable","leadProduct":"PD01A Vaccine","moa":"Undisclosed","graph1":"Neurology","graph2":"Phase I","graph3":"Affiris","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Affiris \/ University Hospital, Bordeaux | INSERM | Forschungszentrum J\u00fclich | University Hospital, Toulouse","highestDevelopmentStatusID":"6","companyTruncated":"Affiris \/ University Hospital, Bordeaux | INSERM | Forschungszentrum J\u00fclich | University Hospital, Toulouse"},{"orgOrder":0,"company":"Affiris","sponsor":"University Hospital T\u00fcbingen","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"AUSTRIA","productType":"Vaccine","year":"2016","type":"Inapplicable","leadProduct":"PD01A Vaccine","moa":"Undisclosed","graph1":"Neurology","graph2":"Phase I","graph3":"Affiris","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Affiris \/ University Hospital T\u00fcbingen","highestDevelopmentStatusID":"6","companyTruncated":"Affiris \/ University Hospital T\u00fcbingen"}]
Find Clinical Drug Pipeline Developments & Deals by Affiris
Filters
×
FILTER:
Company Name
Year
DEALS // DEV.
Country
Sponsor
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Reset All
